StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.65−1.52 (-2.86%)

Close on Nov 17, 2026Market cap $7.18BP/E –Yield –

Cytokinetics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cytokinetics's market cap was $7.28M on Nov 11, 2026, against $8.11M a year earlier. Over the last 5 years it ranged from $2.44M to $8.10B, with a median of $5.80M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$7.28M-3.7%
2025Dec 31, 2025$7.56M+50.3%
2024Dec 31, 2024$5.03M-36.8%
2023Dec 29, 2023$7.97M+99.5%
2022Dec 30, 2022$3.99M+19.1%
2021Dec 31, 2021$3.35M+162.0%
2020Dec 31, 2020$1.28M-99.7%
2019Apr 30, 2019$482.61M+40.8%
2018Dec 31, 2018$342.80M-21.9%
2017Dec 29, 2017$438.98M-10.8%
2016Dec 30, 2016$492.28M+21.4%
2015Dec 31, 2015$405.39M+38.2%
2014Dec 31, 2014$293.24M+52.9%
2013Dec 31, 2013$191.77M+104.0%
2012Dec 31, 2012$93.99M+35.5%
2011Dec 30, 2011$69.39M-42.7%
2010Dec 31, 2010$121.14M–

More Cytokinetics figures

See a number that looks wrong?